Key Opinion Leader Dr. Vinje, Head of the National Calicivirus Laboratory for the Centers for Disease Control & Prevention discusses the health and economic impact and disease burden for norovirus on a conference call to be held on March 28 at 1 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VXRT:
- Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
- Vaxart to host KOL webcast on health, economic impact for norovirus
- Vaxart Provides Business Update and Full Year 2022 Financial Results
- Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
- Vaxart options imply 40.1% move in share price post-earnings